title: Establishment of hypoxia inducible factor-1alpha overexpressing cells that produce endothelin-1.
abstract: Cardiomyocytes produce endothelin-1. Upregulation of endothelin-1 is induced under hypoxic conditions. It has been reported that tissue hypoxia induces transcriptional factor hypoxia inducible factor-1alpha (HIF-1alpha) expression. It has also been reported that cellular hypoxia leads to HIF-1alpha activation. Previously, we reported that HIF-1alpha bound to the site in the ET-1 gene promoter region. HIF-1alpha is a master transcriptional factor that controls transcriptional activation of a number of genes responsive to cellular hypoxia, including endothelin-1, vascular endothelial growth factor, erythropoietin and glycolytic enzymes. We aimed to establish the HIF-1alpha-overexpressing cardiomyocytes. Because it has been reported that HIF-1alpha is destroyed by the ubiquitin proteasome pathway under normoxic conditions, we constructed the point-mutated HIF-1alpha that was exchanged at 564 proline with alanine. The point-mutated HIF-1alpha is not destroyed by ubiquitin proteasome, because ubiquitin ligase cannot bind to the point-mutated area. This mutated HIF-1alpha was transfected to rat cardiomyocytes. Using the protein extraction from the mutated HIF- 1alpha transfected cells under normoxic conditions, western blot methods with anti-HIF-1alpha antibody showed that the band was detected at 120 kDa, which is of identical size to HIF-1alpha. In the normoxic conditions of the control cardiomyocyte cells, the band was undetectable. The endothelin-1 mRNA was significantly altered in HIF-1alpha-overexpressing cells. These results indicate that we have established the cells overexpressing-HIF-1alpha, and that these cells produce endothelin-1 mRNA.
authors.affiliation: Cardiovascular Division, Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Japan.
authors.forename: Masakatsu
authors.initials: M
authors.lastname: Takanashi
authors.forename: Takashi
authors.initials: T
authors.lastname: Miyauchi
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Kakinuma
authors.forename: Katsutoshi
authors.initials: K
authors.lastname: Goto
authors.forename: Iwao
authors.initials: I
authors.lastname: Yamaguchi
mesh_terms: D000818:Animals; D016282:Aspartic Acid Endopeptidases / Q000378:metabolism; D002460:Cell Line; D019332:Endothelin-1 / Q000235:genetics / Q000378:metabolism*; D000072396:Endothelin-Converting Enzymes; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics / Q000378:metabolism*; D008666:Metalloendopeptidases / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000201:enzymology / Q000378:metabolism*; D017354:Point Mutation; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D044022:Receptor, Endothelin A / Q000378:metabolism; D044023:Receptor, Endothelin B / Q000378:metabolism; D014162:Transfection; D015854:Up-Regulation
chemical_list: D019332:Endothelin-1; C497442:HIF1A protein, human; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D012333:RNA, Messenger; D044022:Receptor, Endothelin A; D044023:Receptor, Endothelin B; D016282:Aspartic Acid Endopeptidases; D008666:Metalloendopeptidases; D000072396:Endothelin-Converting Enzymes